Bloodborne pathogens (BBPs) are transmitted from an infected source to a healthy recipient through blood or blood-contaminated media, either percutaneously or transmucosally. Approximately 30 BBPs have been cited in the literature. Pathogens of the highest concern, such as human immunodeficiency virus, hepatitis B, and hepatitis C, among others, pose a significant risk of transmission in dental practices. High global trend of occupational injuries, superimposed with underreporting of exposures, underscores the need for advancement in the prevention, along with robust education in the dental schools. Furthermore, enforcing clear policies on post-exposure reporting and management will enhance safety in dental settings.
Key points
-
•
Dental health care workers remain at an increased risk of occupational exposure to bloodborne pathogens, particularly during high-risk procedures, prompting additional caution.
-
•
Human immunodeficiency virus, hepatitis B, and hepatitis C viruses are of the highest concern. Clinicians should not overlook the potential risk posed by other microorganisms.
-
•
Safety-engineered devices are effective when paired with adequate training programs before implementation into daily practice and consistent monitoring to ensure adherence to best practices.
-
•
Pre-treatment screening of patients can improve risk assessment, enhance awareness, as well as minimize transmission rates.
Abbreviations
| AIDS | Acquired immunodeficiency syndrome |
| BBD | bloodborne disease |
| BBP | bloodborne pathogen |
| CD | communicable disease |
| CDC | Centers for Disease Control and Prevention |
| FDA | Food and Drug Administration |
| HBIG | hepatitis B immune globulin |
| HBsAg | hepatitis B virus surface antigen |
| HBV | hepatitis B virus |
| HCV | hepatitis C virus |
| HCW | health care worker |
| HepB | hepatitis B vaccine |
| HIV | human immunodeficiency virus |
| NAT | nucleic acid test |
| NSI | needlestick injury |
| PEP | post-exposure prophylaxis |
| US | United States |
| VR | virtual reality |
| WHO | World Health Organization |
Introduction
Bloodborne pathogen (BBP) is broadly defined as a biologic entity that is transmitted through blood, which causes disease. Health care workers (HCWs), including dentists and auxiliary staff, are at heightened-risk of exposure to these infectious microorganisms. Percutaneous and or transmucosal injuries are the primary mode of transmission for BBP in the workplace. The most common BBPs of the highest concern in dentistry are hepatitis B (HBV), hepatitis C (HCV), and human immunodeficiency virus (HIV). ,,, Universal precautions by the Occupational Safety and Health Administration have reduced BBP exposures over the last several decades. This article aims to review emerging BBPs and modes of transmission that could occur in a clinical dental practice. Through rigorous infection control practices and education, clinicians can robustly break the chain of transmission, thereby safeguarding themselves, auxiliaries, medical waste handlers, patients, and those accompanying. The purview of this article is not that of a scoping review or a systematic review, but is that of a narrative review.
Definition
The term “blood-borne” is derived from the old English words “blōd” and “beran,” which mean “carried by the blood”. The word “pathogen” is derived from the Greek words “pathos” and “genēs,” implying “disease-causing”. Communicable diseases (CDs), on the contrary, are defined as “diseases caused by pathogenic microorganisms, such as bacteria, viruses, parasites, or fungi; the diseases can be spread, directly or indirectly, from one person to another.” Bloodborne diseases (BBD) are a subset of CD, when specific pathogens from an infected individual (source), through a medium (blood or any other blood-contaminated secretions and media), gain a point of entry (percutaneous, mucocutaneous, or parenteral) into the healthy person’s (recipient) bloodstream.
Historic perspective
Pandemics that sent chills down a physician’s spine included but were not limited to, the Bubonic Plague, the Spanish Flu, the HIV/Acquired immunodeficiency syndrome (AIDS) pandemic, and the COVID-19 pandemic ( Fig. 1 ). Epidemics and pandemics have significantly altered the face of the health care industry including dentistry. Infection control guidelines were limited to a mere verbal transfer of knowledge, until the rise of HBV transmissions in dentistry.
A timeline of the pandemics and epidemics. ,
Prevalence
Increased prevalence of HIV, HBV, and HCV among HCWs is common due to risk of transmission from contaminated blood and body fluids. The Joint United Nations Programme on HIV/AIDS reported 40 million HIV cases in 2023. According to the World Health Organization (WHO), the global prevalence of HBV and HCV in 2022 was estimated to be 250 million chronic cases and half a billion, respectively.
In dentistry, specialities, namely Oral and Maxillofacial Surgery and Periodontics, reported the highest incidences of blood-borne transmissions. Frequent injuries were also reported during fracture reductions, electrocautery, and various procedures involving the use of high-speed instruments. Subgingival scaling utilizing ultrasonic instruments with concomitant use of high-volume evacuator have been shown to minimize blood-contaminated aerosols in Periodontics. , Among general dentists, most injuries reported were due to accidental glove perforation by dental burs, implant drills, improper needle recapping techniques, and other sharp instruments. ,
Most percutaneous injuries in dental schools are during local anesthetic administration. ,, The global estimate of needlestick injury (NSI) prevalence among dental students is approximately 40%. This is primarily due to the lack of 2 factors, clinical experience and chairside assistance. , Additional factors included poor knowledge regarding the proper management of NSI, as well as prophylaxis protocol. , Trends related to occupational exposures in dental schools globally are depicted in Fig. 2 . Generally, there is a high incidence of occupational exposures amongst dental students and interns mainly via percutaneous injuries (see Fig. 2 A), ,,,,,,,,,, as well as low reporting rates (see Fig. 2 B). ,,,,,,, The underreporting can be attributed to fear of stigmatization, as well as the implications of such a report ; on the other hand, other studies have reported that students who did not report the incident had little to no perception of risk or thought of the injury as minor. , The vast majority of students were fully vaccinated against HBV (see Fig. 2 C); ,,,,, however, not all were tested for antibody titers. , Awareness of what constitutes an exposure to BBPs and the definition is generally below optimum as illustrated in Fig. 2 D. ,,,
Mapping world trends in dental schools. ( A ) Incidence of exposure to bloodborne pathogens ( B ) Percentage of exposure reported ( C ) Rate of complete immunization against BBPs ( D ) Awareness regarding post-exposure prophylaxis and management. (Map lines delineate study areas and do not necessarily depict accepted national boundaries.)
Emerging bloodborne pathogens
Studies reveal that more than 30 species can be transmitted by blood from source to recipient. Patients infected by BBDs are potential transmission sources. Clinicians must implement practice protocols in order to ensure safety. A summary of the possible pathogens transmitted by blood and its by-products is given in Table 1 . ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Table 1
Pathogens transmitted by blood and blood by-products ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
| Pathogen | Modes of Transmission | Disease | |
|---|---|---|---|
| Prions | Variant Creutzfeldt-Jakob | Blood transfusion, plasma-derived products | Creutzfeldt-Jakob disease |
| Virus | Viral hemorrhagic fever viruses | Blood and body fluids | Viral hemorrhagic fevers |
| Dengue virus , | Blood and organ transplantation, vector-borne | Dengue | |
| Hepatitis B | Blood and other potentially infectious material (OPIM), mother to child transmission | Hepatitis B | |
| Hepatitis C | Blood and OPIM, mother-to-child transmission | Hepatitis C | |
| Hepatitis D | Blood and parenteral transmission | Hepatitis D | |
| Hepatitis G | Direct bloodstream inoculation, tattoos/piercings, blood transfusion, and organ transplants | Hepatitis G | |
| Herpes simplex virus , | OPIM and mother to child transmission | Herpes | |
| HIV | Direct bloodstream inoculation tattoos/piercings, blood transfusion, and organ transplants | Acquired immunodeficiency syndrome (AIDS) | |
| Cytomegalovirus | Blood products and transplantation | Cytomegalovirus infection (Human betaherpesvirus 5) | |
| Paro viridae | Blood and plasma products | Erythema infectiosum | |
| Epstein-Barr virus | Blood, blood transfusion, and OPIM | Infectious mononucleosis | |
| Varicella-zoster virus | Needlestick injuries | Herpes zoster | |
|
Human T-cell Lymphotropic Virus
Human T-lymphotropic virus type 1 |
Blood transfusion and OPIM | Human T lymphotropic virus infection | |
| Mycoplasma caviae | Needlestick injury | Mycoplasma Infections | |
| Rickettsia rickettsii , | Needlestick injury | Rocky Mountain spotted fever | |
| Rickettsia typhi (typhus) | Blood and plasma products, vector-borne transmission | Murine typhus (endemic typhus) | |
| MRSA | Contaminated instruments and non-intact skin, Organ transplantation , | MRSA endocarditis | |
| Staphylococcus aureus | Blood transmission | Bacteremia | |
| Treponema pallidum | Blood products and organ transplantation, sexually transmitted disease | Syphilis | |
| Yeast | Cryptococcus neoformans , | Needlestick injury | Cryptococcosis |
| Candida tropicalis ,, | Contaminated instruments used for hemodialysis | Candidiasis, Endocarditis, Organ failure | |
| Blastomyces dermatitidis | Scalpel | Blastomycosis (Gilchrist’s disease) | |
| Parasites | Leishmania species | Percutaneous exposure through contaminated needles and sharps | Leishmaniasis |
| Plasmodium falciparum | Vector-borne transmission and blood transfusion | Malaria | |
| Trypanosoma brucei , | Blood transfusion, accidental laboratory exposures, NSI, vector-borne | Sleeping Sickness (African Trypanosomiasis) | |
| Babesia spp | Human-to-human transmission through blood transfusion | Human Babesiosis | |
| Trypanosoma cruzi | Vector-borne, non-vector transmission through blood transfusion, congenital and oral transmission, transplantation | American trypanosomiasis |
Transmission risks in dentistry
Dentists are at a significantly higher risk of acquiring blood-borne infections, commonly due to percutaneous injuries. These pathogens can also be transmitted through sexual contact, needle sharing, NSIs, maternal transmission during pregnancy, birth, or breastfeeding. , Exposure to other potentially infectious materials, body fluids, such as semen, vaginal secretions, saliva, and specific serous fluids; whether visibly tainted or transparent, has the capacity to transmit these pathogens, leading to infectious diseases. Several factors contribute to the risk of transmission in a dental setting ( Fig. 3 ). ,
Factors contributing toward increased risk of transmission.
Within health care environments, transmission typically arises from but is not limited to percutaneous injury, inadvertent puncture, bites, cuts, abrasions, or mucocutaneous contact with fluids from an infected patient ( Fig. 4 ). In an operative setting, sharp instruments used, such as burs, matrix bands, explorers, and curettes, contribute to the majority of the sharp injuries.
Various modes of transmission in dental setting. OPIM, other potentially infectious material.
Advancements in prevention
Sharps with engineered sharps injury protection or safety-engineered devices encompass a wide variety of tools with various mechanisms, both passive and active, that are designed to shield operators and staff from injuries. These devices have demonstrated significant results in reducing such injuries, particularly ones with passive activation mechanisms that activate automatically during use. ,,, Instruments, such as retractable needles, blunted suture needles, and self-sheathing syringes, have been shown to reduce NSIs when paired with adequate training programs. ,, Other ancillary measures aiding in prevention include, but are not limited to, the utilization of magnets, modified suturing and recapping techniques, , and modified personal protection equipment (PPE) textiles. , It must be noted that these additional materials and modifications may demand considerable training and cost. ,,,
Screening, diagnostics, and post-exposure prophylaxis
Human Immunodeficiency Virus
The US Preventive Services Task Force recommends clinicians for HIV screening of individuals aged 15 through 65. Oral fluid and blood-based rapid HIV self-tests (antigen/antibody combination immunoassay, which detects HIV-1/2 antibodies and HIV-1 p24 antigen) were approved by the US Food and Drug Administration (FDA) in 2012 for sale in the United States (US). Very aptly named, they provide results within 30 min. However, the positive results should be re-confirmed with laboratory tests. Identifying oral lesions associated with HIV and prompt referral to a physician, infectious disease specialist or HIV testing facility would accomplish the objectives of the US National HIV/AIDS Strategy. ,
For diagnosis, the latest Centers for Disease Control and Prevention (CDC) guidelines recommend HIV testing with an FDA-approved supplemental HIV-1/2 antibody differentiation immunoassay. In patients with indeterminate results or negative HIV-1/2 antibody results, HIV-1 nucleic acid test (NAT) is recommended (to differentiate between acute HIV-1 infection and false-positive test results) ( Fig. 5 ). ,,
Recommended HIV diagnostic algorithm. HIV, human immunodeficiency virus, NAT, nucleic acid test.
Exposure to the virus mandates the commencement of the post-exposure prophylaxis (PEP). Transmission of HIV can occur rapidly, usually within 24 to 36 h of exposure. Thereby, the HCW should be assessed within 72 h. The status of HIV should be established using rapid combined antigen/antibody or antibody tests. In case of unavailability, PEP must be initiated promptly and can be discontinued if the exposed individual is found to be HIV positive or the source is proven to be HIV negative. PEP involves the administration of antiretroviral medications. ,
Hepatitis B Virus
Updated CDC guidelines recommend triple panel HBV screening tests for all adults at least once in their lifetime to detect HBV surface antigen (HBsAg), antibody to HBsAg (anti-HBsAg), and total antibody to HBV core antigen. , The WHO recommends reconfirmation with a qualitative in-vitro diagnostic test or rapid diagnostic test. , Institutions must ensure that HCWs get prompt post-exposure management and treatment ( Figs. 6 and 7 ), including the hepatitis B immune globulin (HBIG) and hepatitis B vaccine (HepB) vaccines. HBIG and HepB vaccines should be given to susceptible HCWs exposed to HBV as soon as possible after exposure. After 6 mo, HCWs receiving HBIG should be tested for anti-hepatitis B (HB)s to ensure protection (≥10 mIU/mL). ,
Recommended CDC guidelines for hepatitis B vaccinated HCW, for providing management after potential exposure. anti-HBs, hepatitis B surface antigen; ASAP, as soon as possible; HBIG, hepatitis B immune globulin; HBsAg, hepatitis B surface antigen; HCW, healthcare workers; HepB, hepatitis B vaccine; PEP, post-exposure prophylaxis.
Recommended CDC guidelines for hepatitis B unvaccinated HCW, for providing management after potential exposure. anti-HBs, hepatitis B surface antigen; HBIG, hepatitis B immune globulin; HBsAg, hepatitis B surface antigen; HCW, healthcare workers; HepB, hepatitis B vaccine.
Hepatitis C Virus
CDC 2025 guidelines recommend universal HCV screening for all adults older than 18 y. The diagnostic sequence is elaborated in Fig. 8 employing HCV antibody test; if the antibody test results are positive, supplemental NAT is used. Post-exposure treatment for HCV is not recommended for HCWs exposed to blood or body fluids. ,, Data show a very low transmission rate (0.2%) from NSIs and 0% for mucocutaneous exposures. The effectiveness and duration of HCV PEP are not established yet. ,
Recommended testing sequence for diagnosing hepatitis C infection. HCV, hepatitis C virus; PCR, polymerase chain reaction. a Further testing may be warranted depending on the case example (suspected recent HCV exposure, immunocompromised patient, etc).
Education and training
Many educational programs have been established to promote safer practices. In a relatively recent study, virtual reality (VR) has been employed in training sessions. Using VR, a game of right and wrong choices regarding infection control precautions was designed, and has proven effective in decreasing the incidence of sharp injuries. Moreover, the majority of the trainees describe reduced anxiety levels regarding NSIs and the preventive measures required. Another significant facet of these programs is the sensitization of trainees to the perceived threat of occupational exposure to BBPs. This principle is explained by the Health Belief Model, which suggests that for individuals to adopt preventive behaviors, they must first recognize their vulnerability to a risk (perceived susceptibility), comprehend the potential physical and psychologic consequences (perceived severity), and decide to take action if they believe the benefits outweigh any obstacles. When incorporated into educational programs, this model has been effective in raising awareness about NSIs among HCWs by strengthening their perception of health risks and the importance of preventive measures. , Fig. 9 gives a summary of infection prevention guidelines for HCWs.
Infection prevention guidelines for healthcare worker.
Summary
Stringent infection control measures in clinical dental practices remains paramount as HCWs navigate the inherent risks associated with BBPs. While longstanding adherence to universal precautions has significantly mitigated exposure risks, the emergence of new pathogens necessitates a proactive and adaptive approach to infection control. A variety of preventative measures and techniques have been proposed, but it is beyond the purview of this review. It is recommended that educational training programs involve hands-on training on the proper usage, handling and disposal of safety devices to ensure safer practices. Moreover, this should go in tandem with adherence to current infection control protocols and post-exposure management guidelines.
Clinics care points
-
•
Annual educational courses and training programs regarding BBP, PEP, and management (including awareness and implementation of vaccinations and antibody titers) should be mandated in dental schools.
-
•
Educate and motivate dental students and interns to ensure incidents are reported and managed accordingly.
-
•
Clear policies on exposure reporting and post-exposure management should be enforced to enhance safety in dental settings.
Stay updated, free dental videos. Join our Telegram channel
VIDEdental - Online dental courses